Altraz medicine is used to treat early breast cancer in postmenopausal women, either alone or in combination with other treatments such as surgery or radiation therapy. It can also be used as the first-line treatment for advanced breast cancer that has progressed throughout the breast or to other parts of the body.
Altraz is used as follows to treat breast cancer:
In postmenopausal women, it is used as a first-line treatment for breast cancer that has progressed to other parts of their bodies.
Early breast cancer in postmenopausal women can be treated alone or in combination with other treatments such as surgery or radiation.
To treat advanced breast cancer in postmenopausal women.
Altraz inhibits the aromatase enzyme, reducing the amount of estrogen produced in the body. This can reduce or stop the growth of estrogen-sensitive breast cancers. Altraz is normally given as a once-daily oral tablet, and most patients tolerate it well. However, it may induce headaches, nausea, joint discomfort, and bone weakening. Women on Altraz should schedule regular follow-up meetings with their healthcare providers to assess their progress and manage any adverse effects that may arise.
Homepage: Generic cures